TaiMed Biologics Inc.

TaiMed Biologics Inc.verified

4147.TWO

Price:

$63.4

Market Cap:

$17.32B

TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase III clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which completed Phase I clinical trials for treating HIV infec...[Read more]

Industry

Biotechnology

IPO Date

2012-06-20

Stock Exchange

TWO

Ticker

4147.TWO

The Enterprise Value as of December 2025 (TTM) for TaiMed Biologics Inc. (4147.TWO) is 16.98B

According to TaiMed Biologics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.98B. This represents a change of -27.31% compared to the average of 23.36B of the last 4 quarters.

TaiMed Biologics Inc. (4147.TWO) Historical Enterprise Value (quarterly & annually)

How has 4147.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of TaiMed Biologics Inc. over the last ten years is 30.86B. The current 16.98B Enterprise Value has changed 5.40% with respect to the historical average. Over the past ten years (40 quarters), 4147.TWO's Enterprise Value was at its highest in in the June 2018 quarter at 78.13B. The Enterprise Value was at its lowest in in the March 2022 quarter at 16.01B.

Quarterly (TTM)
Annual

Average

30.86B

Median

24.01B

Minimum

18.09B

Maximum

54.29B

TaiMed Biologics Inc. (4147.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of TaiMed Biologics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 56.33%

Maximum Annual Enterprise Value = 54.29B

Minimum Annual Increase = -38.98%

Minimum Annual Enterprise Value = 18.09B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202423.01B8.41%
202321.22B14.14%
202218.59B2.82%
202118.09B-15.95%
202021.52B-14.01%
201925.02B-38.98%
201841.01B-10.67%
201745.90B14.85%
201639.97B-26.38%
201554.29B56.33%

TaiMed Biologics Inc. (4147.TWO) Average Enterprise Value

How has 4147.TWO Enterprise Value performed in the past?

The current Enterprise Value of TaiMed Biologics Inc. (4147.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

20.94B

5-year avg

20.49B

10-year avg

30.86B

TaiMed Biologics Inc. (4147.TWO) Enterprise Value vs. Peers

How is 4147.TWO’s Enterprise Value compared to its peers?

TaiMed Biologics Inc.’s Enterprise Value is less than EirGenix Inc. (17.64B), less than Pell Bio-Med Technology Co., Ltd. (21.75B), less than Sunmax Biotechnology Co., Ltd. (20.88B), greater than Medigen Vaccine Biologics Corporation (12.50B), greater than Tanvex BioPharma, Inc. (16.39B), less than Lin BioScience, Inc. (31.65B), greater than Handa Pharmaceuticals, Inc. (14.16B), less than Caliway Biopharmaceuticals Co., Ltd. (20.17B), less than TTY Biopharm Company Limited (20.51B), greater than Ever Supreme Bio Technology Co., Ltd (14.20B),

Build a custom stock screener for TaiMed Biologics Inc. (4147.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TaiMed Biologics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TaiMed Biologics Inc. (4147.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TaiMed Biologics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is TaiMed Biologics Inc.'s Enterprise Value?

What is the highest Enterprise Value for TaiMed Biologics Inc. (4147.TWO)?

What is the 3-year average Enterprise Value for TaiMed Biologics Inc. (4147.TWO)?

What is the 5-year average Enterprise Value for TaiMed Biologics Inc. (4147.TWO)?

How does the current Enterprise Value for TaiMed Biologics Inc. (4147.TWO) compare to its historical average?